The validity of the patient health Questionnaire-9 to screen for depression in patients with type-2 diabetes mellitus in non-communicable diseases clinics in Malawi

Background Depression is a global problem, affecting populations worldwide, but is too often under-diagnosed. The identification of depression among patients with diabetes is important because depression is prevalent in this group and can complicate diabetes management. Objectives The aim of the stu...

Full description

Saved in:
Bibliographic Details
Published in:BMC psychiatry Vol. 19; no. 1; pp. 81 - 7
Main Authors: Udedi, Michael, Muula, Adamson S., Stewart, Robert C., Pence, Brian W.
Format: Journal Article
Language:English
Published: London BioMed Central 27.02.2019
BioMed Central Ltd
Springer Nature B.V
BMC
Subjects:
ISSN:1471-244X, 1471-244X
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Background Depression is a global problem, affecting populations worldwide, but is too often under-diagnosed. The identification of depression among patients with diabetes is important because depression is prevalent in this group and can complicate diabetes management. Objectives The aim of the study was to determine the sensitivity and specificity of the PHQ-9 in the detection of depression among patients with type-2 diabetes mellitus attending non-communicable diseases (NCD) clinics in Malawi. Methods We conducted a validation study of the Patient Health Questionnaire (PHQ-9) among 323 patients with type-2 diabetes mellitus who attended two NCD clinics in one of the 28 districts of Malawi. The participants were screened consecutively using the nine-item PHQ-9 in Chichewa by a research assistant and completed a diagnostic interview using the Structured Clinical Interview for DSM-IV (SCID) for depression with a mental health clinician. We evaluated both content validity based on expert judgement and criterion validity of the Patient Health Questionnaire (PHQ-9) based on performance against the SCID. The PHQ-9 cutpoint that maximized sensitivity plus specificity was selected to report test characteristics. Results Using the SCID for depression, the prevalence of minor or major depression was 41% (133/323). The internal consistency estimate for the PHQ-9 was 0.83, with an area under the receiver operator curve (AUC) of 0.93 (95% CI, [0.91–0.96]). Using the optimal cut-point of ≥9, the PHQ-9 had a sensitivity of 64% and a specificity of 94% in detecting both minor and major depression, with likelihood ratio-positive = 10.1 and likelihood ratio negative =0.4 as well as overall correct classification (OCC) rate of 81%. Conclusions This is the first validation study of the PHQ-9 in NCD clinics in Malawi. Depression was highly prevalent in this sample. The PHQ-9 demonstrated reasonable accuracy in identifying cases of depression and is a useful screening tool in this setting. Health care workers in NCD clinics can use the PHQ-9 to identify depression among their patients with those having a positive screen followed up by additional diagnostic assessment to confirm diagnosis. Trial registration PACTR201807135104799 . Retrospectively registered on 12 July 2018.
AbstractList Depression is a global problem, affecting populations worldwide, but is too often under-diagnosed. The identification of depression among patients with diabetes is important because depression is prevalent in this group and can complicate diabetes management.BACKGROUNDDepression is a global problem, affecting populations worldwide, but is too often under-diagnosed. The identification of depression among patients with diabetes is important because depression is prevalent in this group and can complicate diabetes management.The aim of the study was to determine the sensitivity and specificity of the PHQ-9 in the detection of depression among patients with type-2 diabetes mellitus attending non-communicable diseases (NCD) clinics in Malawi.OBJECTIVESThe aim of the study was to determine the sensitivity and specificity of the PHQ-9 in the detection of depression among patients with type-2 diabetes mellitus attending non-communicable diseases (NCD) clinics in Malawi.We conducted a validation study of the Patient Health Questionnaire (PHQ-9) among 323 patients with type-2 diabetes mellitus who attended two NCD clinics in one of the 28 districts of Malawi. The participants were screened consecutively using the nine-item PHQ-9 in Chichewa by a research assistant and completed a diagnostic interview using the Structured Clinical Interview for DSM-IV (SCID) for depression with a mental health clinician. We evaluated both content validity based on expert judgement and criterion validity of the Patient Health Questionnaire (PHQ-9) based on performance against the SCID. The PHQ-9 cutpoint that maximized sensitivity plus specificity was selected to report test characteristics.METHODSWe conducted a validation study of the Patient Health Questionnaire (PHQ-9) among 323 patients with type-2 diabetes mellitus who attended two NCD clinics in one of the 28 districts of Malawi. The participants were screened consecutively using the nine-item PHQ-9 in Chichewa by a research assistant and completed a diagnostic interview using the Structured Clinical Interview for DSM-IV (SCID) for depression with a mental health clinician. We evaluated both content validity based on expert judgement and criterion validity of the Patient Health Questionnaire (PHQ-9) based on performance against the SCID. The PHQ-9 cutpoint that maximized sensitivity plus specificity was selected to report test characteristics.Using the SCID for depression, the prevalence of minor or major depression was 41% (133/323). The internal consistency estimate for the PHQ-9 was 0.83, with an area under the receiver operator curve (AUC) of 0.93 (95% CI, [0.91-0.96]). Using the optimal cut-point of ≥9, the PHQ-9 had a sensitivity of 64% and a specificity of 94% in detecting both minor and major depression, with likelihood ratio-positive = 10.1 and likelihood ratio negative =0.4 as well as overall correct classification (OCC) rate of 81%.RESULTSUsing the SCID for depression, the prevalence of minor or major depression was 41% (133/323). The internal consistency estimate for the PHQ-9 was 0.83, with an area under the receiver operator curve (AUC) of 0.93 (95% CI, [0.91-0.96]). Using the optimal cut-point of ≥9, the PHQ-9 had a sensitivity of 64% and a specificity of 94% in detecting both minor and major depression, with likelihood ratio-positive = 10.1 and likelihood ratio negative =0.4 as well as overall correct classification (OCC) rate of 81%.This is the first validation study of the PHQ-9 in NCD clinics in Malawi. Depression was highly prevalent in this sample. The PHQ-9 demonstrated reasonable accuracy in identifying cases of depression and is a useful screening tool in this setting. Health care workers in NCD clinics can use the PHQ-9 to identify depression among their patients with those having a positive screen followed up by additional diagnostic assessment to confirm diagnosis.CONCLUSIONSThis is the first validation study of the PHQ-9 in NCD clinics in Malawi. Depression was highly prevalent in this sample. The PHQ-9 demonstrated reasonable accuracy in identifying cases of depression and is a useful screening tool in this setting. Health care workers in NCD clinics can use the PHQ-9 to identify depression among their patients with those having a positive screen followed up by additional diagnostic assessment to confirm diagnosis.PACTR201807135104799 . Retrospectively registered on 12 July 2018.TRIAL REGISTRATIONPACTR201807135104799 . Retrospectively registered on 12 July 2018.
Background Depression is a global problem, affecting populations worldwide, but is too often under-diagnosed. The identification of depression among patients with diabetes is important because depression is prevalent in this group and can complicate diabetes management. Objectives The aim of the study was to determine the sensitivity and specificity of the PHQ-9 in the detection of depression among patients with type-2 diabetes mellitus attending non-communicable diseases (NCD) clinics in Malawi. Methods We conducted a validation study of the Patient Health Questionnaire (PHQ-9) among 323 patients with type-2 diabetes mellitus who attended two NCD clinics in one of the 28 districts of Malawi. The participants were screened consecutively using the nine-item PHQ-9 in Chichewa by a research assistant and completed a diagnostic interview using the Structured Clinical Interview for DSM-IV (SCID) for depression with a mental health clinician. We evaluated both content validity based on expert judgement and criterion validity of the Patient Health Questionnaire (PHQ-9) based on performance against the SCID. The PHQ-9 cutpoint that maximized sensitivity plus specificity was selected to report test characteristics. Results Using the SCID for depression, the prevalence of minor or major depression was 41% (133/323). The internal consistency estimate for the PHQ-9 was 0.83, with an area under the receiver operator curve (AUC) of 0.93 (95% CI, [0.91–0.96]). Using the optimal cut-point of ≥9, the PHQ-9 had a sensitivity of 64% and a specificity of 94% in detecting both minor and major depression, with likelihood ratio-positive = 10.1 and likelihood ratio negative =0.4 as well as overall correct classification (OCC) rate of 81%. Conclusions This is the first validation study of the PHQ-9 in NCD clinics in Malawi. Depression was highly prevalent in this sample. The PHQ-9 demonstrated reasonable accuracy in identifying cases of depression and is a useful screening tool in this setting. Health care workers in NCD clinics can use the PHQ-9 to identify depression among their patients with those having a positive screen followed up by additional diagnostic assessment to confirm diagnosis. Trial registration PACTR201807135104799 . Retrospectively registered on 12 July 2018.
Depression is a global problem, affecting populations worldwide, but is too often under-diagnosed. The identification of depression among patients with diabetes is important because depression is prevalent in this group and can complicate diabetes management. The aim of the study was to determine the sensitivity and specificity of the PHQ-9 in the detection of depression among patients with type-2 diabetes mellitus attending non-communicable diseases (NCD) clinics in Malawi. We conducted a validation study of the Patient Health Questionnaire (PHQ-9) among 323 patients with type-2 diabetes mellitus who attended two NCD clinics in one of the 28 districts of Malawi. The participants were screened consecutively using the nine-item PHQ-9 in Chichewa by a research assistant and completed a diagnostic interview using the Structured Clinical Interview for DSM-IV (SCID) for depression with a mental health clinician. We evaluated both content validity based on expert judgement and criterion validity of the Patient Health Questionnaire (PHQ-9) based on performance against the SCID. The PHQ-9 cutpoint that maximized sensitivity plus specificity was selected to report test characteristics. Using the SCID for depression, the prevalence of minor or major depression was 41% (133/323). The internal consistency estimate for the PHQ-9 was 0.83, with an area under the receiver operator curve (AUC) of 0.93 (95% CI, [0.91-0.96]). Using the optimal cut-point of ≥9, the PHQ-9 had a sensitivity of 64% and a specificity of 94% in detecting both minor and major depression, with likelihood ratio-positive = 10.1 and likelihood ratio negative =0.4 as well as overall correct classification (OCC) rate of 81%. This is the first validation study of the PHQ-9 in NCD clinics in Malawi. Depression was highly prevalent in this sample. The PHQ-9 demonstrated reasonable accuracy in identifying cases of depression and is a useful screening tool in this setting. Health care workers in NCD clinics can use the PHQ-9 to identify depression among their patients with those having a positive screen followed up by additional diagnostic assessment to confirm diagnosis. PACTR201807135104799 . Retrospectively registered on 12 July 2018.
Abstract Background Depression is a global problem, affecting populations worldwide, but is too often under-diagnosed. The identification of depression among patients with diabetes is important because depression is prevalent in this group and can complicate diabetes management. Objectives The aim of the study was to determine the sensitivity and specificity of the PHQ-9 in the detection of depression among patients with type-2 diabetes mellitus attending non-communicable diseases (NCD) clinics in Malawi. Methods We conducted a validation study of the Patient Health Questionnaire (PHQ-9) among 323 patients with type-2 diabetes mellitus who attended two NCD clinics in one of the 28 districts of Malawi. The participants were screened consecutively using the nine-item PHQ-9 in Chichewa by a research assistant and completed a diagnostic interview using the Structured Clinical Interview for DSM-IV (SCID) for depression with a mental health clinician. We evaluated both content validity based on expert judgement and criterion validity of the Patient Health Questionnaire (PHQ-9) based on performance against the SCID. The PHQ-9 cutpoint that maximized sensitivity plus specificity was selected to report test characteristics. Results Using the SCID for depression, the prevalence of minor or major depression was 41% (133/323). The internal consistency estimate for the PHQ-9 was 0.83, with an area under the receiver operator curve (AUC) of 0.93 (95% CI, [0.91–0.96]). Using the optimal cut-point of ≥9, the PHQ-9 had a sensitivity of 64% and a specificity of 94% in detecting both minor and major depression, with likelihood ratio-positive = 10.1 and likelihood ratio negative =0.4 as well as overall correct classification (OCC) rate of 81%. Conclusions This is the first validation study of the PHQ-9 in NCD clinics in Malawi. Depression was highly prevalent in this sample. The PHQ-9 demonstrated reasonable accuracy in identifying cases of depression and is a useful screening tool in this setting. Health care workers in NCD clinics can use the PHQ-9 to identify depression among their patients with those having a positive screen followed up by additional diagnostic assessment to confirm diagnosis. Trial registration PACTR201807135104799. Retrospectively registered on 12 July 2018.
Background Depression is a global problem, affecting populations worldwide, but is too often under-diagnosed. The identification of depression among patients with diabetes is important because depression is prevalent in this group and can complicate diabetes management. Objectives The aim of the study was to determine the sensitivity and specificity of the PHQ-9 in the detection of depression among patients with type-2 diabetes mellitus attending non-communicable diseases (NCD) clinics in Malawi. Methods We conducted a validation study of the Patient Health Questionnaire (PHQ-9) among 323 patients with type-2 diabetes mellitus who attended two NCD clinics in one of the 28 districts of Malawi. The participants were screened consecutively using the nine-item PHQ-9 in Chichewa by a research assistant and completed a diagnostic interview using the Structured Clinical Interview for DSM-IV (SCID) for depression with a mental health clinician. We evaluated both content validity based on expert judgement and criterion validity of the Patient Health Questionnaire (PHQ-9) based on performance against the SCID. The PHQ-9 cutpoint that maximized sensitivity plus specificity was selected to report test characteristics. Results Using the SCID for depression, the prevalence of minor or major depression was 41% (133/323). The internal consistency estimate for the PHQ-9 was 0.83, with an area under the receiver operator curve (AUC) of 0.93 (95% CI, [0.91–0.96]). Using the optimal cut-point of ≥9, the PHQ-9 had a sensitivity of 64% and a specificity of 94% in detecting both minor and major depression, with likelihood ratio-positive = 10.1 and likelihood ratio negative =0.4 as well as overall correct classification (OCC) rate of 81%. Conclusions This is the first validation study of the PHQ-9 in NCD clinics in Malawi. Depression was highly prevalent in this sample. The PHQ-9 demonstrated reasonable accuracy in identifying cases of depression and is a useful screening tool in this setting. Health care workers in NCD clinics can use the PHQ-9 to identify depression among their patients with those having a positive screen followed up by additional diagnostic assessment to confirm diagnosis. Trial registration PACTR201807135104799. Retrospectively registered on 12 July 2018.
Depression is a global problem, affecting populations worldwide, but is too often under-diagnosed. The identification of depression among patients with diabetes is important because depression is prevalent in this group and can complicate diabetes management. The aim of the study was to determine the sensitivity and specificity of the PHQ-9 in the detection of depression among patients with type-2 diabetes mellitus attending non-communicable diseases (NCD) clinics in Malawi. We conducted a validation study of the Patient Health Questionnaire (PHQ-9) among 323 patients with type-2 diabetes mellitus who attended two NCD clinics in one of the 28 districts of Malawi. The participants were screened consecutively using the nine-item PHQ-9 in Chichewa by a research assistant and completed a diagnostic interview using the Structured Clinical Interview for DSM-IV (SCID) for depression with a mental health clinician. We evaluated both content validity based on expert judgement and criterion validity of the Patient Health Questionnaire (PHQ-9) based on performance against the SCID. The PHQ-9 cutpoint that maximized sensitivity plus specificity was selected to report test characteristics. Using the SCID for depression, the prevalence of minor or major depression was 41% (133/323). The internal consistency estimate for the PHQ-9 was 0.83, with an area under the receiver operator curve (AUC) of 0.93 (95% CI, [0.91-0.96]). Using the optimal cut-point of [greater than or equai to]9, the PHQ-9 had a sensitivity of 64% and a specificity of 94% in detecting both minor and major depression, with likelihood ratio-positive = 10.1 and likelihood ratio negative =0.4 as well as overall correct classification (OCC) rate of 81%. This is the first validation study of the PHQ-9 in NCD clinics in Malawi. Depression was highly prevalent in this sample. The PHQ-9 demonstrated reasonable accuracy in identifying cases of depression and is a useful screening tool in this setting. Health care workers in NCD clinics can use the PHQ-9 to identify depression among their patients with those having a positive screen followed up by additional diagnostic assessment to confirm diagnosis.
Background Depression is a global problem, affecting populations worldwide, but is too often under-diagnosed. The identification of depression among patients with diabetes is important because depression is prevalent in this group and can complicate diabetes management. Objectives The aim of the study was to determine the sensitivity and specificity of the PHQ-9 in the detection of depression among patients with type-2 diabetes mellitus attending non-communicable diseases (NCD) clinics in Malawi. Methods We conducted a validation study of the Patient Health Questionnaire (PHQ-9) among 323 patients with type-2 diabetes mellitus who attended two NCD clinics in one of the 28 districts of Malawi. The participants were screened consecutively using the nine-item PHQ-9 in Chichewa by a research assistant and completed a diagnostic interview using the Structured Clinical Interview for DSM-IV (SCID) for depression with a mental health clinician. We evaluated both content validity based on expert judgement and criterion validity of the Patient Health Questionnaire (PHQ-9) based on performance against the SCID. The PHQ-9 cutpoint that maximized sensitivity plus specificity was selected to report test characteristics. Results Using the SCID for depression, the prevalence of minor or major depression was 41% (133/323). The internal consistency estimate for the PHQ-9 was 0.83, with an area under the receiver operator curve (AUC) of 0.93 (95% CI, [0.91-0.96]). Using the optimal cut-point of [greater than or equai to]9, the PHQ-9 had a sensitivity of 64% and a specificity of 94% in detecting both minor and major depression, with likelihood ratio-positive = 10.1 and likelihood ratio negative =0.4 as well as overall correct classification (OCC) rate of 81%. Conclusions This is the first validation study of the PHQ-9 in NCD clinics in Malawi. Depression was highly prevalent in this sample. The PHQ-9 demonstrated reasonable accuracy in identifying cases of depression and is a useful screening tool in this setting. Health care workers in NCD clinics can use the PHQ-9 to identify depression among their patients with those having a positive screen followed up by additional diagnostic assessment to confirm diagnosis. Trial registration PACTR201807135104799. Retrospectively registered on 12 July 2018. Keywords: PHQ-9, Validation, Non communicable diseases, Depression, Diabetes mellitus, Malawi
ArticleNumber 81
Audience Academic
Author Pence, Brian W.
Muula, Adamson S.
Stewart, Robert C.
Udedi, Michael
Author_xml – sequence: 1
  givenname: Michael
  orcidid: 0000-0001-8769-4313
  surname: Udedi
  fullname: Udedi, Michael
  email: mphatsoudedi@yahoo.co.uk
  organization: Department of Mental Health, University of Malawi, College of Medicine, Department of Clinical Services, Ministry of Health, Department of Public Health, University of Malawi, College of Medicine
– sequence: 2
  givenname: Adamson S.
  surname: Muula
  fullname: Muula, Adamson S.
  organization: Department of Public Health, University of Malawi, College of Medicine, Africa Center of Excellence in Public Health and Herbal Medicine, University of Malawi, College of Medicine
– sequence: 3
  givenname: Robert C.
  surname: Stewart
  fullname: Stewart, Robert C.
  organization: Department of Mental Health, University of Malawi, College of Medicine
– sequence: 4
  givenname: Brian W.
  surname: Pence
  fullname: Pence, Brian W.
  organization: Epidemiology Department, University of North Carolina at Chapel Hill Gillings School of Global Public Health
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30813922$$D View this record in MEDLINE/PubMed
BookMark eNp9ks1u1DAUhSNURH_gAdggS2zYpPgvcbJBqqoClYoQUpHYWY5zM-NRYg-2p1XfhwflptPSTgUoCyfX3znOvT6HxZ4PHoriNaPHjDX1-8R40zQlZW3Jac1L_qw4YFKxkkv5Y-_R-35xmNKKUqaair0o9gVtmGg5Pyh-XS6BXJnR9S7fkDCQjN9rkx34TJZgxrwk3zaQsgveGxehbEkOJNkI4MkQIulhHSEl3CfO30sTuXaozDdrKDnpnekgQyITjKPLmzST2EtpwzRtvLOmGwGpBCYhZUeHtVvoixnNtXtZPB_MmODV3XpUfP94dnn6ubz4-un89OSitDUVuZS8EVbWA65d1QmQgzGtrWhjKimsAgsSWvyTvhe2VU0LQy05h7pXSnaq6sVRcb717YNZ6XV0k4k3OhinbwshLrSJ2dkRdGdqpQZaQytbiRfQUcs546K3YKC3Cr0-bL3Wm27CCg4lmnHHdHfHu6VehCtdi5Y1QqLBuzuDGH7ON6AnlywO0HgIm6Q5axTlolIM0bdP0FXYRI-jQqoVbV3VTD5QC4MNOD8EPNfOpvqkmvNQUTz4qDj-C4VPD5OzmL_BYX1H8OZxo386vM8YAmoL2BhSijBo67KZA4XObtSM6jnNeptmjcPUc5r1rGRPlPfm_9PwrSYh6xcQH2bxb9FvwDQI6g
CitedBy_id crossref_primary_10_3390_healthcare11040598
crossref_primary_10_1080_16549716_2023_2241808
crossref_primary_10_1186_s12888_020_02719_5
crossref_primary_10_1186_s12913_024_11901_4
crossref_primary_10_1007_s10461_022_03852_w
crossref_primary_10_3390_ijerph20043178
crossref_primary_10_1007_s12671_022_02008_0
crossref_primary_10_1007_s10461_019_02593_7
crossref_primary_10_1002_nur_21999
crossref_primary_10_1186_s12888_022_03994_0
crossref_primary_10_1016_j_ijnurstu_2025_105205
crossref_primary_10_3389_fpsyg_2023_1183748
crossref_primary_10_1542_peds_2021_055615
crossref_primary_10_1080_16549716_2020_1783957
crossref_primary_10_1093_inthealth_ihad064
crossref_primary_10_1001_jamanetworkopen_2025_5242
crossref_primary_10_1007_s11154_022_09734_9
crossref_primary_10_1186_s13033_020_00413_3
crossref_primary_10_1111_eip_12885
crossref_primary_10_1155_2020_6486030
crossref_primary_10_3389_fendo_2024_1284799
crossref_primary_10_1097_NCC_0000000000001294
crossref_primary_10_4102_sajid_v35i1_242
crossref_primary_10_1016_j_ajp_2020_102312
crossref_primary_10_1186_s12913_023_10344_7
crossref_primary_10_1016_j_heliyon_2021_e07085
crossref_primary_10_1016_j_jad_2020_10_063
crossref_primary_10_1080_09540121_2023_2195609
crossref_primary_10_1111_ina_13172
crossref_primary_10_1016_S0140_6736_24_01809_9
crossref_primary_10_1186_s13063_021_05601_1
crossref_primary_10_1186_s12888_021_03661_w
crossref_primary_10_4102_phcfm_v13i1_2822
crossref_primary_10_1016_j_yebeh_2020_107475
crossref_primary_10_1186_s13033_021_00480_0
crossref_primary_10_1007_s10461_023_04075_3
crossref_primary_10_1371_journal_pone_0231872
crossref_primary_10_1186_s43045_023_00317_1
crossref_primary_10_2196_25002
crossref_primary_10_1097_JCN_0000000000001118
crossref_primary_10_7759_cureus_33826
crossref_primary_10_1038_s41598_024_62814_5
crossref_primary_10_1371_journal_pone_0234095
crossref_primary_10_1186_s12888_020_02772_0
crossref_primary_10_1007_s12144_022_02997_0
crossref_primary_10_1016_j_jad_2022_03_017
crossref_primary_10_1007_s10461_020_03020_y
crossref_primary_10_3389_fpubh_2024_1326582
crossref_primary_10_1186_s12916_025_04321_6
crossref_primary_10_1111_hsc_13094
crossref_primary_10_1016_j_jad_2025_119863
crossref_primary_10_1136_bmjopen_2025_102236
crossref_primary_10_1186_s12902_019_0473_1
crossref_primary_10_1371_journal_pone_0281711
crossref_primary_10_1136_bmjopen_2022_061801
crossref_primary_10_4103_intv_intv_24_23
crossref_primary_10_7189_jogh_10_020381
crossref_primary_10_4102_sajpsychiatry_v28i0_1647
Cites_doi 10.1016/j.diabres.2014.01.001
10.1111/dme.13611
10.1046/j.1525-1497.2001.016009606.x
10.1016/j.genhosppsych.2007.06.002
10.5588/pha.16.0003
10.1007/s11606-009-0986-9
10.1001/archinte.160.12.1818
10.2337/dc09-1068
10.1016/j.jad.2008.04.001
10.1503/cmaj.110829
10.1016/S0165-0327(02)00237-9
10.1159/000104813
10.4314/rj.v3i1.8F
10.1017/gmh.2016.14
10.1017/S0033291713001141
10.1136/bmj.e609
10.1016/j.genhosppsych.2005.07.004
10.1186/1471-2288-11-116
10.1186/s12888-015-0503-0
10.1002/acr.20556
10.1192/bjp.bp.105.013417
10.1016/j.jad.2008.05.009
10.1111/j.1553-2712.1996.tb03538.x
10.1016/j.jad.2006.05.021
10.1371/journal.pone.0156939
10.1016/j.jad.2012.05.056
10.1016/S0140-6736(07)61415-9
10.1016/j.jad.2015.07.015
ContentType Journal Article
Copyright The Author(s). 2019
COPYRIGHT 2019 BioMed Central Ltd.
Copyright © 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s). 2019
– notice: COPYRIGHT 2019 BioMed Central Ltd.
– notice: Copyright © 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7TK
7X7
7XB
88E
88G
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
K9.
M0S
M1P
M2M
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
7X8
5PM
DOA
DOI 10.1186/s12888-019-2062-2
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Psychology Database (Alumni)
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
ProQuest Central
ProQuest One
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
Psychology Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Publicly Available Content
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Psychology
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Psychology
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Psychology Journals (Alumni)
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest Psychology Journals
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE

Publicly Available Content Database


Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: PIMPY
  name: Publicly Available Content Database
  url: http://search.proquest.com/publiccontent
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1471-244X
EndPage 7
ExternalDocumentID oai_doaj_org_article_ba677f06e9494019b0c22123dceaedc7
PMC6391834
A581395018
30813922
10_1186_s12888_019_2062_2
Genre Validation Study
Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Malawi
Sub-Saharan Africa
Ethiopia
GeographicLocations_xml – name: Malawi
– name: Sub-Saharan Africa
– name: Ethiopia
GrantInformation_xml – fundername: Wellcome Trust
  grantid: DEL-15-01
  funderid: http://dx.doi.org/10.13039/100004440
– fundername: Medical Research Council
  grantid: MC_PC_MR/R01910X/1
– fundername: Wellcome Trust
  grantid: DEL-15-01
– fundername: Wellcome Trust
– fundername: ;
  grantid: DEL-15-01
GroupedDBID ---
0R~
23N
2WC
53G
5VS
6J9
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
ABDBF
ABIVO
ABUWG
ACGFO
ACGFS
ACIHN
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
AZQEC
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CS3
DIK
DWQXO
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EJD
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GNUQQ
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
IPY
ITC
KQ8
M1P
M2M
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PSYQQ
PUEGO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
TUS
UKHRP
W2D
WOQ
WOW
XSB
AAYXX
AFFHD
CITATION
ALIPV
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7TK
7XB
8FK
K9.
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
5PM
ID FETCH-LOGICAL-c603t-4283c46f428b5b3e4faa9c508a543c7ece4e9abedd3c9789ef6422e6d774b75d3
IEDL.DBID RSV
ISICitedReferencesCount 74
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000460111300001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1471-244X
IngestDate Fri Oct 03 12:52:17 EDT 2025
Tue Nov 04 01:55:48 EST 2025
Sun Nov 09 12:24:09 EST 2025
Thu Oct 09 21:40:40 EDT 2025
Tue Nov 11 10:40:54 EST 2025
Tue Nov 04 18:06:19 EST 2025
Mon Jul 21 05:36:28 EDT 2025
Sat Nov 29 01:38:32 EST 2025
Tue Nov 18 21:26:56 EST 2025
Sat Sep 06 07:22:08 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Validation
Non communicable diseases
Depression
PHQ-9
Malawi
Diabetes mellitus
Language English
License Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c603t-4283c46f428b5b3e4faa9c508a543c7ece4e9abedd3c9789ef6422e6d774b75d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Undefined-3
ORCID 0000-0001-8769-4313
OpenAccessLink https://link.springer.com/10.1186/s12888-019-2062-2
PMID 30813922
PQID 2193965614
PQPubID 44775
PageCount 7
ParticipantIDs doaj_primary_oai_doaj_org_article_ba677f06e9494019b0c22123dceaedc7
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6391834
proquest_miscellaneous_2187023571
proquest_journals_2193965614
gale_infotracmisc_A581395018
gale_infotracacademiconefile_A581395018
pubmed_primary_30813922
crossref_citationtrail_10_1186_s12888_019_2062_2
crossref_primary_10_1186_s12888_019_2062_2
springer_journals_10_1186_s12888_019_2062_2
PublicationCentury 2000
PublicationDate 2019-02-27
PublicationDateYYYYMMDD 2019-02-27
PublicationDate_xml – month: 02
  year: 2019
  text: 2019-02-27
  day: 27
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle BMC psychiatry
PublicationTitleAbbrev BMC Psychiatry
PublicationTitleAlternate BMC Psychiatry
PublicationYear 2019
Publisher BioMed Central
BioMed Central Ltd
Springer Nature B.V
BMC
Publisher_xml – name: BioMed Central
– name: BioMed Central Ltd
– name: Springer Nature B.V
– name: BMC
References LE Egede (2062_CR16) 2007; 29
M Mukeshimana (2062_CR7) 2016; 3
G-C Ali (2062_CR30) 2016; 11
2062_CR23
Association, A.P (2062_CR27) 1994
B Al-Otaibi (2062_CR5) 2007; 16
2062_CR26
E Mendenhall (2062_CR33) 2014; 103
E Andreoulakis (2062_CR21) 2012; 16
P Ciechanowski (2062_CR20) 2006; 28
BW Pence (2062_CR11) 2012; 143
P Lai (2062_CR31) 2013; 8
2062_CR4
2062_CR6
RC Ziegelstein (2062_CR17) 2000; 160
F Kauye (2062_CR29) 2014; 44
AO Adewuya (2062_CR8) 2006; 96
2062_CR9
2062_CR10
WF Scholte (2062_CR15) 2011; 11
2062_CR32
RC Manjomo (2062_CR19) 2016; 6
EHB Lin (2062_CR22) 2010; 33
K Kroenke (2062_CR24) 2001; 16
S Moussavi (2062_CR18) 2007; 370
2062_CR1
2062_CR13
NMF Buderer (2062_CR28) 1996; 3
MB First (2062_CR25) 1997
L Manea (2062_CR2) 2012; 184
RC Stewart (2062_CR14) 2009; 112
S Mogga (2062_CR3) 2006; 189
C Hanlon (2062_CR12) 2015; 186
HM Teshome (2062_CR34) 2018; 2018
References_xml – volume: 103
  start-page: 276
  issue: 2
  year: 2014
  ident: 2062_CR33
  publication-title: Diabetes Res Clin Pract
  doi: 10.1016/j.diabres.2014.01.001
– volume-title: Diagnostic and statistical manual of mental disorders (DSM-IV)
  year: 1994
  ident: 2062_CR27
– ident: 2062_CR23
  doi: 10.1111/dme.13611
– volume: 16
  start-page: 606
  issue: 9
  year: 2001
  ident: 2062_CR24
  publication-title: J Gen Intern Med
  doi: 10.1046/j.1525-1497.2001.016009606.x
– volume: 8
  start-page: 2
  issue: 1
  year: 2013
  ident: 2062_CR31
  publication-title: Malays Fam Physician
– volume: 29
  start-page: 409
  issue: 5
  year: 2007
  ident: 2062_CR16
  publication-title: Gen Hosp Psychiatry
  doi: 10.1016/j.genhosppsych.2007.06.002
– volume: 6
  start-page: 60
  issue: 2
  year: 2016
  ident: 2062_CR19
  publication-title: Public Health Action
  doi: 10.5588/pha.16.0003
– ident: 2062_CR10
  doi: 10.1007/s11606-009-0986-9
– volume: 160
  start-page: 1818
  issue: 12
  year: 2000
  ident: 2062_CR17
  publication-title: Arch Intern Med
  doi: 10.1001/archinte.160.12.1818
– volume: 33
  start-page: 264
  issue: 2
  year: 2010
  ident: 2062_CR22
  publication-title: Diabetes Care
  doi: 10.2337/dc09-1068
– volume: 2018
  start-page: 8
  year: 2018
  ident: 2062_CR34
  publication-title: Depress Res Treat
– volume: 112
  start-page: 126
  issue: 1–3
  year: 2009
  ident: 2062_CR14
  publication-title: J Affect Disord
  doi: 10.1016/j.jad.2008.04.001
– ident: 2062_CR26
– volume: 184
  start-page: E191
  issue: 3
  year: 2012
  ident: 2062_CR2
  publication-title: CMAJ : Canadian Medical Association Journal
  doi: 10.1503/cmaj.110829
– ident: 2062_CR32
  doi: 10.1016/S0165-0327(02)00237-9
– volume: 16
  start-page: 384
  issue: 5
  year: 2007
  ident: 2062_CR5
  publication-title: Med Princ Pract
  doi: 10.1159/000104813
– volume: 3
  start-page: 44
  issue: 1
  year: 2016
  ident: 2062_CR7
  publication-title: Rwanda Journal
  doi: 10.4314/rj.v3i1.8F
– ident: 2062_CR1
  doi: 10.1017/gmh.2016.14
– volume: 44
  start-page: 657
  issue: 03
  year: 2014
  ident: 2062_CR29
  publication-title: Psychol Med
  doi: 10.1017/S0033291713001141
– ident: 2062_CR4
  doi: 10.1136/bmj.e609
– volume: 28
  start-page: 9
  issue: 1
  year: 2006
  ident: 2062_CR20
  publication-title: Gen Hosp Psychiatry
  doi: 10.1016/j.genhosppsych.2005.07.004
– volume: 11
  start-page: 116
  issue: 1
  year: 2011
  ident: 2062_CR15
  publication-title: BMC Med Res Methodol
  doi: 10.1186/1471-2288-11-116
– volume: 16
  start-page: 205
  issue: 3
  year: 2012
  ident: 2062_CR21
  publication-title: Hippokratia
– ident: 2062_CR13
  doi: 10.1186/s12888-015-0503-0
– ident: 2062_CR6
  doi: 10.1002/acr.20556
– volume: 189
  start-page: 241
  issue: 3
  year: 2006
  ident: 2062_CR3
  publication-title: Br J Psychiatry
  doi: 10.1192/bjp.bp.105.013417
– ident: 2062_CR9
  doi: 10.1016/j.jad.2008.05.009
– volume: 3
  start-page: 895
  issue: 9
  year: 1996
  ident: 2062_CR28
  publication-title: Acad Emerg Med
  doi: 10.1111/j.1553-2712.1996.tb03538.x
– volume: 96
  start-page: 89
  issue: 1
  year: 2006
  ident: 2062_CR8
  publication-title: J Affect Disord
  doi: 10.1016/j.jad.2006.05.021
– volume: 11
  issue: 6
  year: 2016
  ident: 2062_CR30
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0156939
– volume: 143
  start-page: 208
  issue: 1–3
  year: 2012
  ident: 2062_CR11
  publication-title: J Affect Disord
  doi: 10.1016/j.jad.2012.05.056
– volume-title: Structured clinical interview for DSM-IV clinical version (SCID-I/CV)
  year: 1997
  ident: 2062_CR25
– volume: 370
  start-page: 851
  issue: 9590
  year: 2007
  ident: 2062_CR18
  publication-title: Lancet
  doi: 10.1016/S0140-6736(07)61415-9
– volume: 186
  start-page: 32
  year: 2015
  ident: 2062_CR12
  publication-title: J Affect Disord
  doi: 10.1016/j.jad.2015.07.015
SSID ssj0017851
Score 2.4970613
Snippet Background Depression is a global problem, affecting populations worldwide, but is too often under-diagnosed. The identification of depression among patients...
Depression is a global problem, affecting populations worldwide, but is too often under-diagnosed. The identification of depression among patients with...
Background Depression is a global problem, affecting populations worldwide, but is too often under-diagnosed. The identification of depression among patients...
Abstract Background Depression is a global problem, affecting populations worldwide, but is too often under-diagnosed. The identification of depression among...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 81
SubjectTerms Adult
Ambulatory Care Facilities
Chronic illnesses
Clinics
Communicable diseases
Complications and side effects
Depression
Depression (Mood disorder)
Depression - psychology
Diabetes
Diabetes mellitus
Diabetes Mellitus, Type 2 - psychology
Diabetics
Diagnosis
Diagnostic and Statistical Manual of Mental Disorders
Female
Health care policy
Health screening
Health Status
Health surveys
Humans
Major depressive disorder
Malawi
Male
Medical personnel
Medical research
Medical screening
Medicine
Medicine & Public Health
Mental depression
Mental disorders
Mental health
Middle Aged
Mood disorders
Non communicable diseases
Noncommunicable Diseases - psychology
Patient Health Questionnaire - standards
Patients
PHQ-9
Primary care
Psychiatry
Psychological aspects
Psychotherapy
Questionnaires
Research Article
Retrospective Studies
Risk factors
Sensitivity and Specificity
Surveys and Questionnaires - standards
Systematic review
Type 2 diabetes
Validation
Validity
Workers
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Ni9UwEA-yiHgRv62uEkEQlLBt0-bjuIqLB3fxoLK3kKQpFp59su3b_Yf8Q51J07pdUS-eHrST1yTzy2QmmfxCyAuHqOGFZ5o7CFCU9MyGumZF29ZOVjX38TKYLx_kyYk6PdUfL131hTlhEz3w1HEHzgop21wEXWmIBbTLoTSY28YHGxofz5HnUs_BVNo_wCvn0x5mocTBAFZYYdKWBlSIkpWrWSiS9f9uki_NSVfzJa9smsa56Og2uZWcSHo4Vf4OuRb6u-TGcdomv0d-gPIpQKhrwMem25aCl0cTgyqdTj7SuNIJSuktGD2m6bilYEEgqqXgxtIlQbanXT8XHSiu2lJctWUlnVdt6Tfk9Bx3A0r22575-cyJ2wSaNoAGOh3BjELHdmMvuvvk89G7T2_fs3QdA_Mi5yNDajZfiRZ-Xe14qFprtQcHz9YV9zL4UAUNX24a7iE21aGF2KYMogEP08m64Q_IHtQiPCIUnkgHzopVuaqKxjkOfqWqLaawCGfLjOSzeoxPXOV4ZcbGxJhFCTNp1IBGDWrUQJFXS5HvE1HH34TfoM4XQeTYjg8AeSYhz_wLeRl5iYgxaAmgct6mAw3QROTUMoe1AvcaCRMzsr-ShBHs169nzJlkQQYDMwnXAnlaM_J8eY0lMSuuD9sdyoC1Rb6iIiMPJ4guTeI5_n0JTZUr8K7avH7Td18jvzg4rWDo4buvZ5j_qtYfu_Tx_-jSJ-RmiYMUKQPkPtkbz3bhKbnuz8duOHsWh_hPaW9WRQ
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELagINQL70egICMhIYGsJnESxydUEBUHWnEAtDfLdpwSaUnaTRb-ED-UGcdJSRG9cFopGW88yefxzNj-hpAXBlHDE8skNxCglMIy7fKcJXWdG5Hl3PpiMF8_iuPjcrWSn0LCrQ_bKieb6A111VnMke_DyOKyQN7KN6dnDKtG4epqKKFxlVzDstmIc7GaAy5feD6sZCZlsd-DLS5x65YEbBQpSxdzkafs_9sw_zEzXdw1eWHp1M9Ih7f-V5fb5GbwRenBCJ475Ipr75IbR2G1_R75BRiigMSmAleddjUFZ5EGIlY6HqCkPmEK37bVYDuZpENHwRBBcEzBG6bzPtuWNu3UtKeY_KWY_GUpnZK_9DtSgw7bHiXbrmV2Orpi1o6GdaSejic5vdCRXuufzX3y5fD953cfWKjqwGwR84Ehw5vNihp-TW64y2qtpQU_UecZt8JZlzkJT64qbiHEla6GECl1RQWOqhF5xR-QHeiFe0QoXBEGfB5dxmWWVMZwcE_LXONOmMLoNCLx9H2VDZTnWHljrXzoUxZqhIQCSCiEhIImr-YmpyPfx2XCbxE0syBSdfsL3eZEhZEP3kghRB0XTmYSgllpYoA_-AuAIw1gEhF5iZBTaFCgc1aHcxGgIlJzqYO8BC8deRcjsreQBENgl7cntKlgiHp1DrWIPJ9vY0vcXNe6bosyYLSR9iiJyMMR47NKPMa_T0FVsUD_Quflnbb55mnKwfeF-QKe-3oaJ-fd-ucrfXy5Ek_IborjFzkFxB7ZGTZb95Rctz-Gpt8886P_N0pIY-Q
  priority: 102
  providerName: ProQuest
Title The validity of the patient health Questionnaire-9 to screen for depression in patients with type-2 diabetes mellitus in non-communicable diseases clinics in Malawi
URI https://link.springer.com/article/10.1186/s12888-019-2062-2
https://www.ncbi.nlm.nih.gov/pubmed/30813922
https://www.proquest.com/docview/2193965614
https://www.proquest.com/docview/2187023571
https://pubmed.ncbi.nlm.nih.gov/PMC6391834
https://doaj.org/article/ba677f06e9494019b0c22123dceaedc7
Volume 19
WOSCitedRecordID wos000460111300001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVADU
  databaseName: BioMed Central
  customDbUrl:
  eissn: 1471-244X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017851
  issn: 1471-244X
  databaseCode: RBZ
  dateStart: 20010101
  isFulltext: true
  titleUrlDefault: https://www.biomedcentral.com/search/
  providerName: BioMedCentral
– providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1471-244X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017851
  issn: 1471-244X
  databaseCode: DOA
  dateStart: 20010101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 1471-244X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017851
  issn: 1471-244X
  databaseCode: M~E
  dateStart: 20010101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1471-244X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017851
  issn: 1471-244X
  databaseCode: 7X7
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1471-244X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017851
  issn: 1471-244X
  databaseCode: BENPR
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Psychology Database
  customDbUrl:
  eissn: 1471-244X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017851
  issn: 1471-244X
  databaseCode: M2M
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/psychology
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Publicly Available Content Database
  customDbUrl:
  eissn: 1471-244X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017851
  issn: 1471-244X
  databaseCode: PIMPY
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
– providerCode: PRVAVX
  databaseName: Springer Nature Consortium list (Orbis Cascade Alliance)
  customDbUrl:
  eissn: 1471-244X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017851
  issn: 1471-244X
  databaseCode: RSV
  dateStart: 20011201
  isFulltext: true
  titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22
  providerName: Springer Nature
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bi9QwFA66K-KL98voOkQQBKXYadqmfdyVXRScYVh1GZ9KkqY6MHZkOqN_yB_qd9K02vUC-tKB5mSay5eTk5yTL4w91oQaMTFBLjQWKJk0gbJJEkyqKtEyToRxl8GcvZazWbZY5HN_jrvpot07l6TT1G5YZ-nzBpo0o8CrHD2bRgH07j5mu4zuazh9c9a7Dui2ee--_G22wQTkePp_1cY_TUfnQyXP-UvdNHRy7b8qcJ1d9VYnP2xhcoNdsPVNdnnq_eq32DeghQNzyxJGOV9XHGYh95SrvD0qyd3WKHqxVtCSQc63aw6Vg2Uwh93L-4jami_rLmvDaZuX0zZvEPFum5d_IhLQ7a4hyXpdB6Y7pKJXlnuPUcPbM5tOaKpW6uvyNnt3cvz2xcvA398QmDQU24C43EycVvjViRY2rpTKDSxClcTCSGtsbHN8uSyFwWI2txUWQ5FNS5ikWialuMP2UAp7j3G8kRrWjcrCLJ6UWgsYolmiKOYl1SoasbDr1MJ4cnO6Y2NVuEVOlhZt6xdo_YJav0CWp32Wzy2zx9-EjwgpvSCRcrsX682Hwo9x2B2plFWY2jzOsWzNdQigwzIAeBQQJEfsCeGsINWBwhnlT0CgikTCVRwmGexxYlgcsYOBJIa8GSZ3SC28ymkKTD0iT4nYdcQe9cmUk8LoarvekQzUMxEcTUbsbgvsvkoipL-PUFU5gPygzsOUevnREZLDysXMgO8-64D_o1h_bNL7_yT9gF2JaOQQmYA8YHvbzc4-ZJfMl-2y2YzZRbmQ7pmN2f7R8Wx-Ona7K3hOoynezV9N5-_HTlN8B22GYHc
linkProvider Springer Nature
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3Nb9MwFLdGhxgXvgeFAUYCIYGspXESxweExse0am3Vw0DbydiOA5VKMpqWif-HM38j7-VrZIjdduBUKX5Obef3vuzn9wh5ahA1fGCZ5AYclFhYpl0YskGahkYEIbdlMZiPIzGZxIeHcrpGfjV3YTCsspGJpaBOcot75NvAWVxGmLfy9fE3hlWj8HS1KaFRwWLf_TgBl614NXwH3_eZ7---P3i7x-qqAsxGHl8yzDBmgyiFXxMa7oJUa2nBTtFhwK1w1gVOauOShFtwsaRLwUT3XZSAoWREmHB47yWyHiDYe2R9OhxPj9pzCyx1X5-dDuJouwDpH2OwmAQ0Rj7zO9qvLBLwtyr4QxeejdM8c1hb6sDd6__b6t0g12prm-5U7HGTrLnsFrkyruMJbpOfwCUUeG2WgDNC85SCOUzrVLO0uiJKyy1hQG-mQTswSZc5BVEL7j8Fe5-2kcQZnWVN14Li9jbF7W3m02Z7m37F5KfLVYGUWZ4x21zOMXNH65OyglZ3VUuisZ7rk9kd8uFC1miT9GAU7h6h8EQYsOp07MXBIDGGgwEehxpjfSKj_T7xGjwpWyd1x9oic1U6d3GkKggqgKBCCCro8qLtclxlNDmP-A2CtCXEZOTlg3zxWdWyDeytSIjUi5wMJLjr0njA4GARAW41gFf0yXOEuEKRCYOzur75AVPE5GNqJ4zBD8HMkn2y1aEEUWe7zQ26VS1qC3UK7T550jZjTwwfzFy-QhpQS5jYadAndyueaqfEPXy9D1MVHW7rzLnbks2-lInYwboHjQj_-7Lhy9Nh_XNJ758_icdkY-9gPFKj4WT_Abnqo-zADApii_SWi5V7SC7b78tZsXhUyx5KPl00w_4GI1fEEA
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3bbtQwELVQQRUv5d4GChgJCQlkNRsndvxYLisQ7aoSUPXNsh0HVlqSapOFH-JDmUmcQMpFQjytlIw3vozHZzzjY0IeW9QaPnNMcQsOSi4dMz7L2KwsMyvTjLvuMpjTI7lY5Gdn6iTcc9oM2e5DSLI_04AsTVV7cF6U_RTPxUEDVjXHJCwFoywSBjb4cop59Oiuvzsdwwh483wIZf622GQx6jj7f7XMPy1NF9MmL8ROuyVpfu2_G3Od7AQ0Sg979blBLvnqJtk-DvH2W-QbaBEFXVwWANZpXVKAizRQsdL-CCXttkxhdCsD1pMp2tYUTBG4xxTwMB0zbSu6rIaiDcXtX4rbvyyhw_Yv_YzkoO2mQcmqrpgbDq_YlachktTQ_ixnJ3RsVubr8jb5MH_1_sVrFu51YE7EvGXI8eZSUcKvzSz3aWmMcoAUTZZyJ73zqVfw5aLgDpxc5UtwkhIvCoCqVmYFv0O2oBZ-j1B4Ii2gHpPHeTorrOUAUPPMYC6MsCaJSDwMsHaB9Bzv3ljpzvnJhe57X0Pva-x9DUWejkXOe8aPvwk_R60ZBZGsu3tQrz_qMPcBjwgpy1h4lSpwZ5WNYQIAYgBFMqBNMiJPUOc0mhSonDPhZAQ0Ecm59GGWA05H5sWI7E8kwRS46etBa3UwRY2GJYkrgYSvEXk0vsaSmF5X-XqDMmC2kfhoFpHdXsnHJvEY_z6BpsqJ-k_aPH1TLT91ROWAfmHFgO8-GybBj2r9sUvv_pP0Q7J98nKuj94s3t4jVxOcRMg3IPfJVrve-PvkivvSLpv1g84wfAfzw2VC
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+validity+of+the+patient+health+Questionnaire-9+to+screen+for+depression+in+patients+with+type-2+diabetes+mellitus+in+non-communicable+diseases+clinics+in+Malawi&rft.jtitle=BMC+psychiatry&rft.au=Udedi%2C+Michael&rft.au=Muula%2C+Adamson+S.&rft.au=Stewart%2C+Robert+C.&rft.au=Pence%2C+Brian+W.&rft.date=2019-02-27&rft.pub=BioMed+Central&rft.eissn=1471-244X&rft.volume=19&rft.issue=1&rft_id=info:doi/10.1186%2Fs12888-019-2062-2&rft.externalDocID=10_1186_s12888_019_2062_2
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-244X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-244X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-244X&client=summon